缺血性脑卒中是一组临床症候群,主要表现为脑梗死及短暂性脑缺血发作(TIA),具有较高的发病率、致残率和病死率,给患者家庭和社会带来沉重的负担。由于该病具有较高的复发率,而且复发后的致残率和病死率更高,因此预防患者缺血性脑卒中的复发尤为重要。随着对缺血性脑卒中发病机制及药物预防研究的不断深入,近年来,人们逐渐认识到缺血性脑卒中是最可预防的严重疾病之一,积极的预防往往可获得良好的效果。我们于2007年12月至2009年6月通过比较阿司匹林联合阿托伐他汀 Ischemic stroke is a group of clinical syndromes, mainly manifested as cerebral infarction and transient ischemic attack (TIA), with a high incidence, disability and mortality, to patients with heavy family and society burden. As the disease has a high recurrence rate, and post-relapse morbidity and mortality higher, so to prevent recurrence of ischemic stroke in patients is particularly important. With the deepening of the research on the pathogenesis of ischemic stroke and drug prevention, in recent years, people have come to realize that ischemic stroke is one of the most preventable serious diseases, and positive prevention can often achieve good results. We compared aspirin with atorvastatin from December 2007 to June 2009